Alexis Callahan | executive |
Sheldon Koenig | executive |
Benjamin Halladay | executive |
Yuchen Ding | analyst |
Thomas Shrader | analyst |
Eric Warren | executive |
Troy Langford | analyst |
Joanne Foody | executive |
Jason Zemansky | analyst |
Serge Belanger | analyst |
Betty Swartz | executive |
Ladies and gentlemen, thank you for standing by, and welcome to Esperion Therapeutics Third Quarter 2023 Financial Results Call. [Operator Instructions] Please be advised that today's conference may be recorded. I would now like to hand the conference over to Alexis Callahan, Head of Investor Relations at Esperion. Please go ahead, Alexis.
Thank you, operator.